Which of the following medications are included in the category of MAOIs?

Monoamine Oxidase Inhibitors (MAOIs) are a specific class of medications used primarily to treat depression, particularly atypical depression and treatment-resistant depression. MAOIs work by inhibiting the action of monoamine oxidase, an enzyme responsible for breaking down neurotransmitters such as serotonin, norepinephrine, and dopamine in the brain. By preventing the breakdown of these neurotransmitters, MAOIs increase their levels and can lead to an improvement in mood and emotional state.

The classification of antidepressant medications is broad, and while there are various categories including SSRIs, SNRIs, and tricyclics, only the choice correctly identifies a medication class that directly aligns with the MAOI classification. MAOIs are known for their specific mechanism and historical significance in the development of antidepressant therapies.

In summary, the reason the answer is correct lies in the direct alignment of the term "Monoamine Oxidase Inhibitors" with the medication class being queried, as opposed to the other categories mentioned, which are distinct classes with different mechanisms of action and indications.